Bio Green Med Solution, Inc. (BGMS)
0.88
0.00 (0.00%)
USD |
NASDAQ |
Oct 05, 16:00
0.88
0.00 (0.00%)
After-Hours: 20:00
Bio Green Med Solution Net Income (Quarterly) : -0.405M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.405M |
| March 31, 2026 | -0.197M |
| December 31, 2025 | -10.15M |
| September 30, 2025 | -2.482M |
| June 30, 2025 | -1.25M |
| March 31, 2025 | -4.206M |
| December 31, 2024 | -3.05M |
| September 30, 2024 | -1.957M |
| June 30, 2024 | -3.257M |
| March 31, 2024 | -2.946M |
| December 31, 2023 | -5.271M |
| September 30, 2023 | -6.032M |
| June 30, 2023 | -5.448M |
| March 31, 2023 | -5.804M |
| December 31, 2022 | -7.42M |
| September 30, 2022 | -5.096M |
| June 30, 2022 | -4.575M |
| March 31, 2022 | -4.108M |
| December 31, 2021 | -5.294M |
| September 30, 2021 | -4.987M |
| June 30, 2021 | -5.127M |
| March 31, 2021 | -3.478M |
| December 31, 2020 | -2.804M |
| September 30, 2020 | -2.256M |
| June 30, 2020 | -2.166M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.22M |
| December 31, 2019 | -2.303M |
| September 30, 2019 | -1.901M |
| June 30, 2019 | -1.783M |
| March 31, 2019 | -1.842M |
| December 31, 2018 | -2.018M |
| September 30, 2018 | -2.068M |
| June 30, 2018 | -1.852M |
| March 31, 2018 | -1.349M |
| December 31, 2017 | -1.871M |
| September 30, 2017 | -1.857M |
| June 30, 2017 | -2.187M |
| March 31, 2017 | -1.555M |
| December 31, 2016 | -2.839M |
| September 30, 2016 | -2.946M |
| June 30, 2016 | -2.965M |
| March 31, 2016 | -3.041M |
| December 31, 2015 | -3.374M |
| September 30, 2015 | -2.709M |
| June 30, 2015 | -3.347M |
| March 31, 2015 | -4.912M |
| December 31, 2014 | -4.799M |
| September 30, 2014 | -4.911M |
| June 30, 2014 | -4.819M |
| March 31, 2014 | -4.877M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Supermax Corp. Bhd. | 19.95M |
| YD Bio Ltd. | -2.215M |
| ALPS Group, Inc. | -0.8284M |
| Cencora, Inc. | 776.67M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.336M |
| Total Expenses (Quarterly) | 0.741M |
| EPS Diluted (Quarterly) | -0.0759 |
| Enterprise Value | 2.038M |
| Gross Profit Margin (Quarterly) | 23.51% |
| Profit Margin (Quarterly) | -120.5% |
| Earnings Yield | -412.7% |
| Normalized Earnings Yield | -412.73 |